Daunorubicin‐45 Vs. Daunorubicin‐60 for Induction in Intermediate‐Age Patients of <scp>AML</scp> : Results From a Randomized Trial
Authors
- K Liu
- B C Liu
- Shaowei Qiu (ORCID: https://orcid.org/0000-0003-3866-0066)
- Jianxiang Wang (ORCID: https://orcid.org/0000-0001-9437-9151)
- Li Li (ORCID: https://orcid.org/0009-0003-4636-9487)
- Hui Wei
- Yan Li
- Qiuyun Fang
- Chunlin Zhou
- Yingchang Mi
- Ying Wang
- Dong Lin
- Benfa Gong
- Xiaoyuan Gong
- Guangji Zhang
- Yuntao Liu
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Institute of Hematology & Blood Diseases Hospital (CN)
Publication Details
- Journal
- Cancer Science
- Published
- 2026-04-15
- DOI
- https://doi.org/10.1111/cas.70383
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China